These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 37386008)

  • 1. The proteomic landscape of soft tissue sarcomas.
    Burns J; Wilding CP; Krasny L; Zhu X; Chadha M; Tam YB; Ps H; Mahalingam AH; Lee ATJ; Arthur A; Guljar N; Perkins E; Pankova V; Jenks A; Djabatey V; Szecsei C; McCarthy F; Ragulan C; Milighetti M; Roumeliotis TI; Crosier S; Finetti M; Choudhary JS; Judson I; Fisher C; Schuster EF; Sadanandam A; Chen TW; Williamson D; Thway K; Jones RL; Cheang MCU; Huang PH
    Nat Commun; 2023 Jun; 14(1):3834. PubMed ID: 37386008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic profiling of soft tissue sarcomas with SWATH mass spectrometry.
    Milighetti M; Krasny L; Lee ATJ; Morani G; Szecsei C; Chen Y; Guljar N; McCarthy F; Wilding CP; Arthur A; Fisher C; Judson I; Thway K; Cheang MCU; Jones RL; Huang PH
    J Proteomics; 2021 Jun; 241():104236. PubMed ID: 33895336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Implications and Molecular Features of Extracellular Matrix Networks in Soft Tissue Sarcomas.
    Pankova V; Krasny L; Kerrison W; Tam YB; Chadha M; Burns J; Wilding CP; Chen L; Chowdhury A; Perkins E; Lee ATJ; Howell L; Guljar N; Sisley K; Fisher C; Chudasama P; Thway K; Jones RL; Huang PH
    Clin Cancer Res; 2024 Aug; 30(15):3229-3242. PubMed ID: 38810090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
    Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
    BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic characterization identifies clinically relevant subgroups of soft tissue sarcoma.
    Tang S; Wang Y; Luo R; Fang R; Liu Y; Xiang H; Ran P; Tong Y; Sun M; Tan S; Huang W; Huang J; Lv J; Xu N; Yao Z; Zhang Q; Xu Z; Yue X; Yu Z; Akesu S; Ding Y; Xu C; Lu W; Zhou Y; Hou Y; Ding C
    Nat Commun; 2024 Feb; 15(1):1381. PubMed ID: 38360860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deconvolution of sarcoma methylomes reveals varying degrees of immune cell infiltrates with association to genomic aberrations.
    Simon M; Mughal SS; Horak P; Uhrig S; Buchloh J; Aybey B; Stenzinger A; Glimm H; Fröhling S; Brors B; Imbusch CD
    J Transl Med; 2021 May; 19(1):204. PubMed ID: 33980253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MET gene copy number alterations and expression of MET and hepatocyte growth factor are potential biomarkers in angiosarcomas and undifferentiated pleomorphic sarcomas.
    Schmitz K; Koeppen H; Binot E; Fassunke J; Künstlinger H; Ihle MA; Heydt C; Wardelmann E; Büttner R; Merkelbach-Bruse S; Rüschoff J; Schildhaus HU
    PLoS One; 2015; 10(4):e0120079. PubMed ID: 25844809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current molecular and therapeutic advances in liposarcoma, rhabdomyosarcoma, leiomyosarcoma, synovial sarcoma, and angiosarcoma.
    Tanriverdi O; Yildiz A
    J Oncol Pharm Pract; 2022 Apr; 28(3):635-645. PubMed ID: 35043739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Chromosomes and MorPhology.
    Mertens F; Fletcher CD; Dal Cin P; De Wever I; Mandahl N; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; Van den Berghe H; Vanni R; Willén H
    Genes Chromosomes Cancer; 1998 May; 22(1):16-25. PubMed ID: 9591630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune-cell infiltration in high-grade soft tissue sarcomas; prognostic implications of tumor-associated macrophages and B-cells.
    Nyström H; Jönsson M; Nilbert M; Carneiro A
    Acta Oncol; 2023 Jan; 62(1):33-39. PubMed ID: 36786033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines.
    Salawu A; Fernando M; Hughes D; Reed MW; Woll P; Greaves C; Day C; Alhajimohammed M; Sisley K
    Br J Cancer; 2016 Oct; 115(9):1058-1068. PubMed ID: 27560552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncopig Soft-Tissue Sarcomas Recapitulate Key Transcriptional Features of Human Sarcomas.
    Schachtschneider KM; Liu Y; Mäkeläinen S; Madsen O; Rund LA; Groenen MAM; Schook LB
    Sci Rep; 2017 Jun; 7(1):2624. PubMed ID: 28572589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
    Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL
    Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic signatures corresponding to histological classification and grading of soft-tissue sarcomas.
    Suehara Y; Kondo T; Fujii K; Hasegawa T; Kawai A; Seki K; Beppu Y; Nishimura T; Kurosawa H; Hirohashi S
    Proteomics; 2006 Aug; 6(15):4402-9. PubMed ID: 16807943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic profiling improves prognostic risk stratification of the Sarculator nomogram in soft tissue sarcomas of the extremities and trunk wall.
    Chadha M; Iadecola S; Jenks A; Pankova V; Tam YB; Burns J; Arthur A; Wilding CP; Chen L; Chudasama P; Callegaro D; Strauss DC; Thway K; Gronchi A; Jones RL; Miceli R; Pasquali S; Huang PH
    Cancer Med; 2024 Jul; 13(14):e70026. PubMed ID: 39041188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Undifferentiated and dedifferentiated soft tissue neoplasms: Immunohistochemical surrogates for differential diagnosis.
    Thway K; Fisher C
    Semin Diagn Pathol; 2021 Nov; 38(6):170-186. PubMed ID: 34602314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-152 down-regulation is associated with MET up-regulation in leiomyosarcoma and undifferentiated pleomorphic sarcoma.
    Pazzaglia L; Novello C; Conti A; Pollino S; Picci P; Benassi MS
    Cell Oncol (Dordr); 2017 Feb; 40(1):77-88. PubMed ID: 27900663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities.
    Koelsche C; Renner M; Hartmann W; Brandt R; Lehner B; Waldburger N; Alldinger I; Schmitt T; Egerer G; Penzel R; Wardelmann E; Schirmacher P; von Deimling A; Mechtersheimer G
    J Exp Clin Cancer Res; 2014 Apr; 33(1):33. PubMed ID: 24726063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic and Metabolomic Profiling in Soft Tissue Sarcomas.
    Chadha M; Huang PH
    Curr Treat Options Oncol; 2022 Jan; 23(1):78-88. PubMed ID: 35171456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis of uterine sarcomas and rare uterine mesenchymal tumours with malignant potential. Guidelines of the French Sarcoma Group and Rare Gynaecological Tumours].
    Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Le Frere Belda MA; Averous G; Leroux A; Bataillon G; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
    Bull Cancer; 2024 Jan; 111(1):97-116. PubMed ID: 37806863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.